OTC · Drug Manufacturers - Specialty & Generic

CannaPharmaRX, Inc. (CPMD) Stock

$0.00 OTC: CPMD Healthcare

CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector.

Valuation

MetricValue
Price$0.00
Market Cap$1.42M
P/E Ratio-0.13
P/B Ratio-0.05
P/S Ratio1.42
EPS (TTM)$-0.02
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE36.67%
ROA-157.14%
ROCE13.46%
Gross Margin-400.00%
Operating Margin-300.00%
Net Margin-1100.00%
Debt/Equity-0.70
Current Ratio0.03

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$1.0M$1.0M
Operating Profit$-3.0M$-5.0M$-2.0M$-4.0M$-3.0M
Net Profit$-9.0M$-9.0M$4.0M$-10.0M$-11.0M
EPS$-0.12$-0.04$0.01$-0.02$-0.02
Op Margin-439.7%-245.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$5.0M$12.0M$11.0M$7.0M
Total Liabilities$13.0M$23.0M$24.0M$31.0M$37.0M
Cash$0$0$0$0$0
Borrowings$9.0M$15.0M$13.0M$14.0M$21.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-1.0M$-2.0M$-2.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$1.0M$2.0M$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-2.0M$-2.0M$-2.0M$-2.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.72
FCF Yield-30.66%
Quick Ratio0.00
Interest Coverage-1.38
Return 1Y-30.00%
Return 3Y-85.00%
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALIDAllied Corp. $0.00 0.00 $57748 0.00%
APPBApplied Biosciences Corp. $0.00 0.00 $1365 0.00%
CBDYTarget Group Inc. $0.00 -0.41 $740431 0.00%
CNNACann American Corp. $0.01 +8.33% 0.53 $4.80M 0.00%
EXMTAnything Technologies Media, Inc. $0.00 -6.00 $1.44M 0.00%

About CannaPharmaRX, Inc.

CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.

CannaPharmaRX, Inc. (CPMD) stock trades at $0.00 with a market capitalization of $1.42M. The stock is valued at a price-to-earnings (P/E) ratio of -0.13, price-to-book of -0.05, price-to-sales of 1.42. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, CannaPharmaRX, Inc. generates a return on equity (ROE) of 36.67% — well above the market average, a sign of a high-quality business, return on capital employed of 13.46%, an operating margin of -300.00%, a net profit margin of -1100.00%.

Official website: www.cannapharmarx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides